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JCB: EDITORIAL
The Journal of Cell Biology has orga-
nized its first ever scientific conference. 
Why? There  are  several  good  reasons. 
For one, the JCB is first and foremost a 
community journal. It is run by scientists 
for  scientists,  and  we  consider  it  our 
mission to bring scientists together, be 
it  by  communicating  science  in  our 
pages, on our web-based forums such as 
our biobytes and biosights podcasts, our 
biowrites blog, on our Facebook page, or 
as of recently on Twitter. Holding a scien-
tific  conference  follows  that  spirit  of 
connecting the cell biology community.
A strong motivation for us to hold 
a meeting is our deep belief that the JCB 
is not merely a middleman in the com-
munication of science, but that a primary 
goal of the journal, and the community 
it represents, is to define the future of 
cell biology. We have done this for many 
years by leading the way on policy is-
sues such as public access to the scien-
tific literature and data integrity. More 
importantly,  the  journal  advances  the 
field  by  identifying,  highlighting,  and 
supporting new areas of cell biological 
research. The first JCB meeting, jointly 
organized with the New York Academy 
of Sciences and held in New York on 
September 23–25, 2009, focused on one 
such  rapidly  emerging  area:  the  Cell   
Biology of Disease.
In  contrast  with  decades  past, 
contemporary cell biology is more than 
just basic science. Cell biology is now 
an  applied  and  medically  relevant   
discipline—and increasingly so. Some 
of today’s best cell biology is done in 
models of disease, differentiation, and 
developmental systems, and many cell 
biological  observations  are  rapidly 
translated  into  biotechnological  and 
medical applications.
Cell biology applied to diseases is 
highly relevant and impacts the future 
of biomedical research. We now realize 
that  the  simple  identification  of  a   
disease-causing gene is not sufficient to 
fully  understand  disease  pathology. 
Truly understanding a disease is to un-
cover the cell biological consequences 
of any disease mutation. After all, all 
diseases are caused by cell biological 
defects. A complete characterization of 
the in vivo cellular behavior of disease 
cells is also essential for the develop-
ment of successful therapeutic applica-
tions. Without cell biology, there are no 
effective therapies.
But the cell biological elucidation 
of disease is a two-way street. Diseases 
are also a powerful tool for cell biologists 
to probe their favorite process in vivo. 
While elucidation of defective pathways 
leads to a deeper understanding of dis-
ease symptoms and eventually to cures, 
the  aberrant  nature  of  a  given  cellular 
process  in  a  disease  cell  represents  an   
in vivo experiment whose results often 
prove  informative  about  how  cellular 
processes  are  organized  under  normal 
circumstances. There is no better cell   
biological test tube than a disease cell.
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The New York City skyline as viewed from the New York Academy of Sciences’ conference space where the JCB Cell Biology of Disease meeting was held.
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Now is the time to vigorously em-
bark  on  a  cellular  investigation  of  dis-
eases. Outstanding cell biology work over 
recent decades has led to the description 
and  thorough,  albeit  still  incomplete, 
characterization of the molecular basis of 
most fundamental cellular processes. At 
the same time, genomic approaches are 
identifying disease genes at an unprece-
dented  rate.  Every  time  a  new  disease 
gene is identified, we can tap into the vast 
accumulated  cell  biological  knowledge 
and rapidly interrogate the affected path-
ways. Cell biology, in that sense, is a   
direct, and necessary, extension of gene-
hunting efforts. The confluence of a broad 
molecular  description  of  cellular  pro-
cesses and the surge in identification of 
disease genes begs for a strong commit-
ment by the cell biology community to 
apply its knowledge to disease.
The JCB meeting focused on three 
large topics particularly relevant to dis-
ease:  chromosomes,  cancer,  and  stem 
cells.  An  array  of  tantalizing  science 
was presented by world leaders in their 
field  and  by  a  hand-picked  group  of 
some  of  the  most  outstanding  up-and-
coming young investigators. The science 
explored the often unexpected links be-
tween these areas ranging from the role 
of chromatin in stem cells, genome in-
stability in cancer, the importance of mi-
gration in metastasis, or the contribution 
of stem cells to aging and cancer. A de-
tailed description of the scientific con-
tent is available on our biowrites blog, 
Facebook, and Twitter.
The take-home message from the 
meeting is clear: Cell biologists do not 
need  to  choose  between  investigating 
fundamental  cellular  processes  and 
studying  disease  mechanisms.  Both 
can—and should—be done at the same 
time by investigating the cell biology of 
disease.  When  we  do  cell  biology  in   
disease systems, everyone wins.
Web addresses are as follows:
biobytes, http://jcb.rupress.org/biobytes
biosights, http://jcb.rupress.org/biosights
biowrites, http://jcb-biowrites.rupress.org
Facebook, http://www.facebook.com/JCellBiol
Twitter, http://twitter.com/jcellbiol
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